1. Home
  2. ZVRA vs HYLN Comparison

ZVRA vs HYLN Comparison

Compare ZVRA & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.82

Market Cap

562.2M

Sector

Health Care

ML Signal

HOLD

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

HOLD

Current Price

$3.77

Market Cap

631.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
HYLN
Founded
2006
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
562.2M
631.3M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
ZVRA
HYLN
Price
$9.82
$3.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$23.00
$5.00
AVG Volume (30 Days)
1.5M
2.5M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
159.21
N/A
EPS
0.60
N/A
Revenue
$106,470,000.00
$3,475,000.00
Revenue This Year
$37.27
$197.93
Revenue Next Year
$53.42
$301.97
P/E Ratio
$15.85
N/A
Revenue Growth
350.91
130.28
52 Week Low
$7.16
$1.47
52 Week High
$15.04
$8.49

Technical Indicators

Market Signals
Indicator
ZVRA
HYLN
Relative Strength Index (RSI) 32.87 43.91
Support Level $9.53 $1.78
Resistance Level $11.07 $4.56
Average True Range (ATR) 0.56 0.37
MACD -0.33 0.04
Stochastic Oscillator 17.33 41.66

Price Performance

Historical Comparison
ZVRA
HYLN

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.

Share on Social Networks: